02181.HK
Mabpharm Limited
HKSE · Healthcare · Biotechnology · CN
HKD 0.39
−7.14%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 16.27x
- PEG TTM
- —
- Price / book
- 7.10x
- Price / sales
- 1.80x
- Price / cash flow
- 13.82x
Enterprise value
- Enterprise value
- HKD 1.9B
- EV / sales
- 2.08x
- EV / EBITDA
- 16.57x
- EV / EBIT
- 43.42x
- Market cap
- HKD 1.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026